High-mobility group box 1 protein activating nuclear factor-κB to upregulate vascular endothelial growth factor C is involved in lymphangiogenesis and lymphatic node metastasis in colon cancer

Journal of International Medical Research

Volumn 43, Issue 4, 2015, Pages 494-505

  Li, Yan ^a,b   He, Jianming ^a   Zhong, Daping ^a   Li, Jianjun ^a   Liang, Houjie ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

colon cancer; High mobility group box 1 protein; lymphangiogenesis; metastasis; nuclear factor B; vascular endothelial growth factor C

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PODOPLANIN; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CAPILLARY DENSITY; COLON CANCER; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; HCT116 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MALE; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TISSUE LEVEL; TUMOR DIFFERENTIATION; UPREGULATION; COLON TUMOR; METABOLISM; NONPARAMETRIC TEST; PATHOLOGY;

COLONIC NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; HCT116 CELLS; HMGB1 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; NF-KAPPA B; STATISTICS, NONPARAMETRIC; TRANSFECTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84936946555     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060515581671     Document Type: Article

References (36)

1. C.NorrménT.TammelaT.V.Petrova. Biological basis of therapeutic lymphangiogenesis. Circulation2011; 123: 1335–1351.
2. L.Le GuenT.KarpanenD.Schulte. Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis. Development2014; 141: 1239–1249.
3. T.MajimaK.TakeuchiK.Sano. An adaptor molecule afadin regulates lymphangiogenesis by modulating RhoA activity in the developing mouse embryo. PLoS One2013; 8: e68134–e68134.
4. C.A.WangP.JedlickaA.N.Patrick. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. J Clin Invest2012; 122: 1895–1906.
5. F.G.GomesF.NedelA.M.Alves. Tumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms. Life Sci2013; 92: 101–107.
6. R.CaoH.JiN.Feng. Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis. Proc Natl Acad Sci USA2012; 109: 15894–15899.
7. R.C.Ji. Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis. Cell Mol Life Sci2012; 69: 897–914.
8. R.KangQ.ZhangH.J.Zeh3rd. HMGB1 in cancer: good, bad, or both?Clin Cancer Res2013; 19: 4046–4057.
9. F.BiscettiG.StrafaceR.De Cristofaro. High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. Diabetes2010; 59: 1496–1505.
10. H.X.YanH.P.WuH.L.Zhang. p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release. J Hepatol2013; 59: 762–768.
11. J.R.van BeijnumP.Nowak-SliwinskaE.van den Boezem. Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1. Oncogene2013; 32: 363–374.
12. M.BuoncervelloP.BorghiG.Romagnoli. Apicidin and docetaxel combination treatment drives CTCFL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast cancer cells. Neoplasia2012; 14: 855–867.
13. P.ScaffidiT.MisteliM.E.Bianchi. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature2002; 418: 191–195.
14. N.KalininaA.AgrotisY.Antropova. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler Thromb Vasc Biol2004; 24: 2320–2325.
15. J.M.CrawfordV.KumarThe oral cavity and the gastrointestinal tract. In: V.KumarR.S.CotranS.L.Robbins (eds). Basic Pathology, 7th ed. Beijing: Elsevier, 2003, pp. 543–590.
16. M.NakayamaA.NakayamaM.van Lessen. Spatial regulation of VEGF receptor endocytosis in angiogenesis. Nat Cell Biol2013; 15: 249–260.
17. J.ValencakE.Heere-RessT.Kopp. Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma. Eur J Cancer2004; 40: 358–364.
18. J.A.MorenoC.SastreJ.Madrigal-Matute. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes. Arterioscler Thromb Vasc Biol2013; 33: 612–620.
19. N.KhromovaP.KopninV.Rybko. Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms. Oncogene2012; 31: 1389–1397.
20. J.M.HeF.C.WangH.B.Qi. Down-regulation of alphav integrin by retroviral delivery of small interfering RNA reduces multicellular resistance of HT29. Cancer Lett2009; 284: 182–188.
21. R.Reeves. Nuclear functions of the HMG proteins. Biochim Biophys Acta2010; 1799: 3–14.
22. X.WangH.F.BuW.Zhong. MFG-E8 and HMGB1 are involved in the mechanism underlying alcohol-induced impairment of macrophage efferocytosis. Mol Med2013; 19: 170–182.
23. I.PolletC.J.OpinaC.Zimmerman. Bacterial lipopolysaccharide directly induces angiogenesis through TRAF6-mediated activation of NF-kappaB and c-Jun N-terminal kinase. Blood2003; 102: 1740–1742.
24. Y.CarmiE.VoronovS.Dotan. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. J Immunol2009; 183: 4705–4714.
25. G.LigrestiA.C.AplinP.Zorzi. Macrophage-derived tumor necrosis factor-alpha is an early component of the molecular cascade leading to angiogenesis in response to aortic injury. Arterioscler Thromb Vasc Biol2011; 31: 1151–1159.
26. R.BansalT.TomarA.Ostman. Selective targeting of interferon gamma to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth. Mol Cancer Ther2012; 11: 2419–2428.
27. V.PatelC.A.MarshR.T.Dorsam. Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer. Cancer Res2011; 71: 7103–7112.
28. A.BracherA.S.CardonaS.Tauber. Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis. J Invest Dermatol2013; 133: 230–238.
29. L.J.FitzJ.C.MorrisP.Towler. Characterization of murine Flt4 ligand/VEGF-C. Oncogene1997; 15: 613–618.
30. C.I.LinC.N.ChenM.T.Huang. Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms. Cell Signal2008; 20: 1804–1814.
31. H.WuJ.B.XuY.L.He. Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer. J Surg Oncol2012; 106: 462–468.
32. M.R.JungT.H.LeeM.H.Bang. Suppression of thymus- and activation-regulated chemokine (TARC/CCL17) production by 3-O-β-D-glucopyanosylspinasterol via blocking NF-κB and STAT1 signaling pathways in TNF-α and IFN-γ-induced HaCaT keratinocytes. Biochem Biophys Res Commun2012; 427: 236–241.
33. C.W.LiW.XiaL.Huo. Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1. Cancer Res2012; 72: 1290–1300.
34. J.H.KimS.J.KimI.S.Lee. Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway. J Immunol2009; 182: 2458–2466.
35. Z.LiuY.ChangJ.Zhang. Magnesium deficiency promotes secretion of high-mobility group box 1 protein from lipopolysaccharide-activated macrophages in vitro. J Surg Res2013; 180: 310–316.
36. Y.LiuL.WangT.Kikuiri. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α. Nat Med2011; 17: 1594–1601.